Publications by authors named "S T Lwin"
Service Interruption in HIV Care Amid COVID-19 Pandemic in Myanmar: Results From Analysis of Routine Program Data 2018-2022.
J Int Assoc Provid AIDS Care
December 2024
Background: COVID-19 pandemic disrupted organized HIV screening efforts, HIV testing and management worldwide, and the impact of these disruptions from private HIV care clinics have not been examined in Myanmar. PSI/Myanmar had adapted through partner clinics, Sun Quality Health Clinics (SQH) and Lan Pya Kyel clinics (LPK), with measures like online booking, staff scheduling and awareness campaigns. The purpose of this paper was to describe whether HIV-related services changed before, during, and after the COVID-19 pandemic in Myanmar.
View Article and Find Full Text PDFCampylobacter jejuni is a leading cause of foodborne illness worldwide. The application of bacteriophages offers a promising approach to specifically target and reduce C. jejuni contamination in food products.
View Article and Find Full Text PDFArticle Synopsis
- Advances in medicine are finding cures for diseases previously deemed incurable, including some types of cancer.
- Traditional definitions of "cure" involve the complete resolution of disease at both clinical and molecular levels, maintaining this state even after treatment ends.
- For psoriasis, combining biologic therapies with personalized medicine and lifestyle changes may restore immune balance and achieve a cure, despite current treatments mostly leading to relapses.
Article Synopsis
- A recent cross-sectional study conducted by dermatologists from Denmark, the UK, and Switzerland in May 2022 assessed the prevalence of skin diseases among adults in Tasiilaq, East Greenland, revealing significant health concerns.* -
- Out of 295 participants (about 22.5% of the adult population), 69% exhibited visible signs of skin disease, with common conditions being hand eczema, lichen simplex, and scabies being the most prevalent.* -
- The findings highlight a high prevalence of skin diseases and emphasize the need for improved access to dermatological care in the region, as many cases were severe and differed from typical presentations.*
Endolysin, a bacteriophage-derived lytic enzyme, has emerged as a promising alternative antimicrobial agent against rising multidrug-resistant bacterial infections. Two novel endolysins LysPEF1-1 and LysPEF1-2 derived from phage PEF1 were cloned and overexpressed in to test their antimicrobial efficacy against multidrug-resistant strains and their biofilms. LysPEF1-1 comprises an enzymatically active domain and a cell-wall-binding domain originating from the NLPC-P60 and SH3 superfamilies, while LysPEF1-2 contains a putative peptidoglycan recognition domain that belongs to the PGRP superfamily.
View Article and Find Full Text PDF